Kooriyama; Yuuji

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kooriyama; Yuuji.The latest application filed is for "sulfur-containing heterocyclic derivative having beta secretase inhibitory activity".

Company Profile

0.11.15

Kooriyama; Yuuji - Osaka JP
KOORIYAMA; Yuuji - Osaka-shi JP
Kooriyama; Yuuji - Osaka-fu JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Sulfur-containing heterocyclic derivative having beta secretase inhibitory activity Grant 9,650,371 - Hori , et al. May 16, 2	2017-05-16
Sulfur-containing Heterocyclic Derivative Having Beta Secretase Inhibitory Activity App 20160326158 - HORI; Akihiro ; et al.	2016-11-10
Sulfur-containing Heterocyclic Derivative Having Beta Secretase Inhibitory Activity App 20160108052 - Hori; Akihiro ; et al.	2016-04-21
Sulfur-containing heterocyclic derivative having Beta secretase inhibitory activity Grant 9,273,053 - Matsumoto , et al. March 1, 2	2016-03-01
Sulfur-containing Heterocyclic Derivative Having Beta Secretase Inhibitory Activity App 20150105379 - Matsumoto; Sae ; et al.	2015-04-16
Naphthyridine derivative Grant 8,927,721 - Mitsuoka , et al. January 6, 2	2015-01-06
Pharmaceutical composition for treating alzheimer's disease Grant 8,895,548 - Kobayashi , et al. November 25, 2	2014-11-25
Aminodihydrothiazine derivatives substituted with a cyclic group Grant 8,884,062 - Tamura , et al. November 11, 2	2014-11-11
2-aminopyrimidin-4-one and 2-aminopyridine derivatives both having BACE1-inhibiting activity Grant 8,703,785 - Yonezawa , et al. April 22, 2	2014-04-22
Aminodihydrothiazine Derivatives Substituted With A Cyclic Group App 20140073815 - TAMURA; Yuusuki ; et al.	2014-03-13
Pharmaceutical Composition For Treating Alzheimer's Disease App 20140058097 - Kobayashi; Naotake ; et al.	2014-02-27
Aminodihydrothiazine derivatives substituted with a cyclic group Grant 8,541,408 - Tamura , et al. September 24, 2	2013-09-24
Naphthyridine Derivative App 20130217705 - Mitsuoka; Yasunori ; et al.	2013-08-22
4-amino-1,3-thiazine Or Oxazine Derivative App 20120258961 - Suzuki; Shinji ; et al.	2012-10-11
Fused Heterocyclic Compound Having Amino Group App 20120245155 - Yoshida; Syuhei ; et al.	2012-09-27
Aminodihydrothiazine Derivatives Substituted With A Cyclic Group App 20120172355 - TAMURA; Yuusuke ; et al.	2012-07-05
Aminodihydrothiazine derivatives substituted with a cyclic group Grant 8,168,630 - Tamura , et al. May 1, 2	2012-05-01
Isothiourea Derivatives Or Isourea Derivatives Having Bace1 Inhibitory Activity App 20120015961 - Tamura; Yuusuke ; et al.	2012-01-19
2-aminopyrimidin-4-one And 2-aminopyridine Derivatives Both Having Bace1-inhibiting Activity App 20110237576 - Yonezawa; Shuji ; et al.	2011-09-29
Sulfur-containing Heterocyclic Derivative Having Beta Secretase Inhibitory Activity App 20110190279 - Hori; Akihiro ; et al.	2011-08-04
Pharmaceutical Composition For Treating Alzheimer's Disease App 20100160290 - Kobayashi; Naotake ; et al.	2010-06-24
Aminodihydrothiazine Derivatives Substituted With A Cyclic Group App 20100075957 - Tamura; Yuusuke ; et al.	2010-03-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.